ÌÇÐÄÆƽâ°æ

Skip to main content

Number of biosimilars approved annually by the FDA from 2015 to 2025

Number of biosimilars approved by FDA 2015-2025

Last update:
Jan 29, 2026
Author:
ÌÇÐÄÆƽâ°æ Research Department
Region:
United States
Survey time period:
From 01/01/2015 to 31/12/2025

Related insights

Number of biosimilar drugs becoming available United States 2015-2022
USA
Cumulative number of drugs with biosimilars approved US and Europe 2006-2018
CAN
Biosimilars approved for marketing Europe vs U.S. 2022 by year since approval
USA
Biosimilars in development and approved by FDA 2019, by manufacturer
USA
Novel medical technology products approved by FDA 2015-2023
USA
Number of biosimilars approved by PMDA Japan 2010-2019
JPN
FDA approved orphan drugs 1983-2018, by approval sequence
USA
Savings through biosimilar use in the U.S. 2015-2024
USA
Number of novel drugs approved annually by CDER 2008-2025
USA
New U.S. biosimilar launches of top products 2024-2029
USA
Number of approved ANDAs in U.S. 2009-2023
USA
Number of therapies approved globally 2020-2024, by modality
Worldwide
Sales of biosimilars one year before patent expiry 2025-2034
USA
Number of FDA approved NMEs, 2009-2018, by size of drug owner
USA
Global market forecast of biosimilars 2023-2033
Worldwide
Biopharmaceutical approvals in Germany 2018-2024, by drug type
DEU
Consumption volume of biosimilar drugs in Italy 2016-2023
ITA
VR and AR medical devices approved by the FDA in the U.S. 2015-2025
USA
Cumulative potential biosimilars market in EU5 countries and the U.S. 2016-2020
USA
Country-wise biosimilar pipelines number in development worldwide 2017
Worldwide
We’re happy to help

Get in touch with us for additional information

Feel free to contact us anytime. We will respond to your inquiry as quickly as possible.

Get in touch